$INUV
Inuvo, Inc. Stock $inuv

$inuv Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000165495424005713 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$18.21M	$17.02M
YoY Change	9.35%	43.69%
Cost Of Revenue	$2.906M	$2.099M
YoY Change	22.7%	-34.21%
Gross Profit	$15.30M	$14.92M
YoY Change	7.14%	72.4%
Gross Profit Margin	84.04%	87.67%
Selling, General & Admin	$17.00M	$17.02M
YoY Change	18.33%	40.72%
% of Gross Profit	111.11%	114.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$430.7K	$673.2K
YoY Change	-38.96%	5.35%
% of Gross Profit	2.81%	4.51%
Operating Expenses	$17.00M	$17.02M
YoY Change	-3.52%	40.72%
Operating Profit	-$1.699M	-$2.091M
YoY Change	-49.11%	-39.13%
Interest Expense	-$42.45K	-$20.38K
YoY Change	11.16%	6.59%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00
YoY Change		-100.0%
Pretax Income	-$1.742M	-$2.112M
YoY Change	-48.42%	-38.62%
Income Tax	$5.353K
% Of Pretax Income
Net Earnings	-$1.747M	-$2.112M
YoY Change	-48.27%	-38.62%
Net Earnings / Revenue	-9.6%	-12.4%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.01	-$0.02
COMMON SHARES
Basic Shares Outstanding	139.9M shares	139.2M shares
Diluted Shares Outstanding	140.1M shares	138.8M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.012M	$2.432M
YoY Change	-60.12%	23.48%
Cash & Equivalents	$2.012M	$2.000M
Short-Term Investments
Other Short-Term Assets	$1.038M	$1.019M
YoY Change	25.28%	4.99%
Inventory
Prepaid Expenses	$1.038M	$1.019M
Receivables	$8.081M	$8.710M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$11.13M	$12.16M
YoY Change	-33.22%	0.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.757M	$1.726M
YoY Change	4.55%	2.29%
Goodwill	$9.853M	$9.853M
YoY Change	0.0%	0.0%
Intangibles	$4.173M	$4.419M
YoY Change	-19.09%	-18.22%
Long-Term Investments
YoY Change
Other Assets	$128.3K	$53.35K
YoY Change	-81.27%	-20.28%
Total Long-Term Assets	$17.33M	$17.61M
YoY Change	-1.64%	-2.65%
TOTAL ASSETS
Total Short-Term Assets	$11.13M	$12.16M
Total Long-Term Assets	$17.33M	$17.61M
Total Assets	$28.46M	$29.78M
YoY Change	-16.99%	-1.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.076M	$5.331M
YoY Change	-1.89%	-3.2%
Accrued Expenses	$7.601M	$8.030M
YoY Change	-7.77%	62.79%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change		-100.0%
Long-Term Debt Due	$27.37K	$38.19K
YoY Change	-63.06%	-55.74%
Total Short-Term Liabilities	$13.95M	$13.63M
YoY Change	-4.66%	20.34%
LONG-TERM LIABILITIES
Long-Term Debt	$5.970K	$12.12K
YoY Change	-82.09%	-76.17%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities	$972.3K	$1.037M
YoY Change	530.4%	484.64%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.95M	$13.63M
Total Long-Term Liabilities	$972.3K	$1.037M
Total Liabilities	$14.92M	$14.67M
YoY Change	0.92%	27.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$171.3M	-$169.6M
YoY Change	4.53%	5.64%
Common Stock	$140.4K	$139.4K
YoY Change	1.9%	14.62%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.54M	$15.10M
YoY Change
Total Liabilities & Shareholders Equity	$28.46M	$29.78M
YoY Change	-16.99%	-1.26%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$1.747M	-$2.112M
YoY Change	-48.27%	-38.62%
Depreciation, Depletion And Amortization	$430.7K	$673.2K
YoY Change	-38.96%	5.35%
Cash From Operating Activities	$195.4K	-$1.356M
YoY Change	-50.79%	-58.04%
INVESTING ACTIVITIES
Capital Expenditures	$461.7K	$472.2K
YoY Change	8.59%	14.83%
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change	-100.0%
Cash From Investing Activities	-$461.7K	-$472.2K
YoY Change	8.59%	-125.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-153.8K	-$180.7K
YoY Change	-104.95%	-146.15%
NET CHANGE
Cash From Operating Activities	195.4K	-$1.356M
Cash From Investing Activities	-461.7K	-$472.2K
Cash From Financing Activities	-153.8K	-$180.7K
Net Change In Cash	-420.1K	-$2.008M
YoY Change	-113.66%	108.82%
FREE CASH FLOW
Cash From Operating Activities	$195.4K	-$1.356M
Capital Expenditures	$461.7K	$472.2K
Free Cash Flow	-$266.3K	-$1.828M
YoY Change	849.75%	-49.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16523294	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1725938	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1680788	usd
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000829323
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	137983918	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139428784	shares
CY2024Q1	inuvo	Number Of Patents Pending NumberOfPatentsPending	8	integer
CY2021Q3	inuvo	Referral Agreement Term ReferralAgreementTerm	P5Y
CY2021Q3	inuvo	Class Of Warrant Or Right Vesting Period ClassOfWarrantOrRightVestingPeriod	P2Y
CY2024Q1	inuvo	Reduction In Commission Expense ReductionInCommissionExpense	52000	usd
CY2023Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2350314	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y
CY2024Q1	inuvo	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate	0	pure
CY2021Q3	inuvo	Class Of Warrant Or Right Term ClassOfWarrantOrRightTerm	P7Y
CY2021Q3	inuvo	Class Of Warrant Or Right Number Of Tranches ClassOfWarrantOrRightNumberOfTranches	2	integer
CY2021Q3	inuvo	Warrant And Rights Outstanding Term WarrantAndRightsOutstandingTerm	P7Y
	us-gaap	Operating Lease Expense OperatingLeaseExpense	282580	usd
CY2023Q3	inuvo	Lessee Operating Leases Term Of Contract LesseeOperatingLeasesTermOfContract	P65M
CY2023Q3	inuvo	Lessee Operating Lease Abatement Period LesseeOperatingLeaseAbatementPeriod	P5M
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	202904	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-32442
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	INUVO, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0450450
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	500 President Clinton Ave.
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Little Rock
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AR
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	72201
CY2024Q1	dei	City Area Code CityAreaCode	501
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	205-8508
CY2024Q1	dei	Security12b Title Security12bTitle	Common stock
CY2024Q1	dei	Trading Symbol TradingSymbol	INUV
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	139883999	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2431957	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4440454	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	487158	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1645045	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8710358	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9226956	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1018876	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1076121	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	12161191	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	14743531	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1725938	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1680788	usd
CY2024Q1	us-gaap	Goodwill Goodwill	9853342	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4418666	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4664791	usd
CY2024Q1	inuvo	Referral Agreement ReferralAgreement	425000	usd
CY2023Q4	inuvo	Referral Agreement ReferralAgreement	500000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1084113	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	805786	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	53911	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	72560	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53346	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	53346	usd
CY2024Q1	inuvo	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	15888378	usd
CY2023Q4	inuvo	Other Assets Total Noncurrent OtherAssetsTotalNoncurrent	15949825	usd
CY2024Q1	us-gaap	Assets Assets	29775507	usd
CY2023Q4	us-gaap	Assets Assets	32374144	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5330807	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6432120	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8030395	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7926479	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	233919	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	123074	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	38186	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	50801	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	13633307	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14532474	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	89238	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	89238	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	935977	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	751821	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	12118	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	18209	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	216	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1037333	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	859484	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139428784	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	137983918	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	139428	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	137983	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	184524308	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	184291414	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-169558869	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167447211	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	15104867	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16982186	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29775507	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32374144	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17023777	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11847440	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2099042	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3190563	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	14924735	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	8656877	usd
CY2024Q1	inuvo	Advertising Costs AdvertisingCosts	13102644	usd
CY2023Q1	inuvo	Advertising Costs AdvertisingCosts	7087550	usd
CY2024Q1	us-gaap	Salaries And Wages SalariesAndWages	3224859	usd
CY2023Q1	us-gaap	Salaries And Wages SalariesAndWages	3422841	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	688510	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1581889	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	17016013	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	12092280	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2091278	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3435403	usd
CY2024Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20380	usd
CY2023Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-19120	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14418	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111658	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3440105	usd
CY2024Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	84868	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2111658	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3355237	usd
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	138789669	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	120970597	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138789669	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	120970597	shares
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-2111658	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-3440105	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	673203	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	639026	usd
CY2024Q1	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	18649	usd
CY2023Q1	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	30642	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	396312	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	432084	usd
CY2024Q1	inuvo	Grant Expenses GrantExpenses	-5000	usd
CY2023Q1	inuvo	Stock Issued For Vested Restricted Stock Awards Amount StockIssuedForVestedRestrictedStockAwardsAmount	0	usd
CY2023Q1	inuvo	Grant Expenses GrantExpenses	5000	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	833	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2083	usd
CY2024Q1	inuvo	Adjustment To Expected Loss On Accounts Receivable AdjustmentToExpectedLossOnAccountsReceivable	-1100000	usd
CY2023Q1	inuvo	Adjustment To Expected Loss On Accounts Receivable AdjustmentToExpectedLossOnAccountsReceivable	-38875	usd
CY2024Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-14418	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9874	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1616597	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2037941	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	75000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	75000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	57245	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-171434	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	124540	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-240104	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1101313	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2537965	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1355592	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3230999	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	472228	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	411238	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2288876	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-472228	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1877638	usd
CY2024Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	592868	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	18705	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	34467	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	161972	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	166872	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-180677	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	391529	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2008497	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-961832	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4440454	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2931415	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2431957	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1969583	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	36914	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	29953	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	335286	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	16982186	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-2111658	usd
CY2024Q1	inuvo	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Values AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues	396312	usd
CY2024Q1	inuvo	Stock Issued For Vested Restricted Stock Awards Amount StockIssuedForVestedRestrictedStockAwardsAmount	0	usd
CY2024Q1	inuvo	Shares Withheld For Taxes On Vested Restricted Stock SharesWithheldForTaxesOnVestedRestrictedStock	-161973	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	15104867	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	21749316	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-3440105	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	84868	usd
CY2023Q1	inuvo	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Values AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValues	432084	usd
CY2023Q1	inuvo	Shares Withheld For Taxes On Vested Restricted Stock SharesWithheldForTaxesOnVestedRestrictedStock	-166872	usd
CY2023Q1	inuvo	Adjustments To Additional Paid In Capital Change In Warrant Vesting AdjustmentsToAdditionalPaidInCapitalChangeInWarrantVesting	-9874	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	18649417	usd
CY2024Q1	inuvo	Number Of Patents Issued NumberOfPatentsIssued	19	integer
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2000000	usd
CY2024Q1	inuvo	Working Capital Net WorkingCapitalNet	1500000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The preparation of financial statements, in accordance with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net revenues and expenses and disclosure of contingent assets and liabilities. The estimates and assumptions used in the accompanying consolidated financial statements are based upon management’s regular evaluation of the relevant facts and circumstances as of the date of the consolidated financial statements. We regularly evaluate estimates and assumptions related to capitalized labor, goodwill and purchased intangible asset valuations and income tax valuation allowance. Actual results may differ from the estimates and assumptions used in preparing the accompanying consolidated financial statements, and such differences could be material.</p>
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	17023777	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11847440	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16950372	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18676310	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18204082	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16950372	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16523294	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1725938	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1680788	usd
CY2024Q1	us-gaap	Depreciation Depreciation	427078	usd
CY2023Q1	us-gaap	Depreciation Depreciation	392901	usd
CY2024Q1	inuvo	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2024Q1	inuvo	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	13146334	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4418666	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	246125	usd
CY2024Q1	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2024Q1	us-gaap	Goodwill Goodwill	9853342	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	523792	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	469500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	469500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	469500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	469500	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1626875	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4028667	usd
CY2023Q4	inuvo	Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross	17565000	usd
CY2023Q4	inuvo	Intangible Assets Accumulated Amortizationand Impairment Loss IntangibleAssetsAccumulatedAmortizationandImpairmentLoss	12900209	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4664791	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	984500	usd
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	9853342	usd
CY2023Q4	us-gaap	Goodwill Goodwill	9853342	usd
CY2024Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5695372	usd
CY2023Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	5717983	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1364098	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1544460	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	938026	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	622960	usd
CY2024Q1	inuvo	Accrued Grant Current AccruedGrantCurrent	30000	usd
CY2023Q4	inuvo	Accrued Grant Current AccruedGrantCurrent	35000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2899	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6076	usd
CY2024Q1	inuvo	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	8030395	usd
CY2023Q4	inuvo	Accrued Liabilities And Lease Liability Current AccruedLiabilitiesAndLeaseLiabilityCurrent	7926479	usd
CY2021Q3	inuvo	Referral Agreement ReferralAgreement	1500000	usd
CY2021Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	300000	shares
CY2024Q1	inuvo	Amortization Of Referral Agreement As Marketing Expense AmortizationOfReferralAgreementAsMarketingExpense	775000	usd
CY2023Q3	inuvo	Commission Offset Amount CommissionOffsetAmount	960852	usd
CY2023Q3	us-gaap	Accounts Receivable Purchase AccountsReceivablePurchase	642202	usd
CY2023	inuvo	Reduction In Commission Expense ReductionInCommissionExpense	67000	usd
CY2023	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	52000	usd
CY2024Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	17000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	42167778	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41000516	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1256500	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	89238	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	396312	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	432084	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2517485	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8413345	shares
CY2024Q1	inuvo	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Exercised SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesExercised	8485792	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	7650863	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	24550000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	7010016	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.48
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3255000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.41
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	1851671	shares
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.87
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	8413345	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.37
CY2021Q3	inuvo	Class Of Warrant Or Right Granted In Period ClassOfWarrantOrRightGrantedInPeriod	300000	shares
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.72
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	149551	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	85862	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	21136	shares
CY2023	inuvo	Shares Vested Reversed Due Hange In The Probability Of Performance Criteria SharesVestedReversedDueHangeInTheProbabilityOfPerformanceCriteria	7900000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	193000	shares
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1084113	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	53911	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	805786	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	72560	usd
CY2024Q1	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	18649	usd
CY2023Q1	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	30642	usd
CY2023Q3	inuvo	Lessee Operating Lease Area Of Office Space LesseeOperatingLeaseAreaOfOfficeSpace	4128	sqft
CY2023Q3	inuvo	Lessee Operating Lease Lease Not Yet Commenced Lease Cost Year One LesseeOperatingLeaseLeaseNotYetCommencedLeaseCostYearOne	208000	usd
CY2023Q3	inuvo	Lessee Operating Lease Annual Increase In Lease Cost Percentage LesseeOperatingLeaseAnnualIncreaseInLeaseCostPercentage	0.03	pure
CY2024Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	127000	usd
	inuvo	Finance And Operating Lease Right Of Use Asset Amortization FinanceAndOperatingLeaseRightOfUseAssetAmortization	2	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	56364	usd
CY2024Q1	inuvo	Weighted Average Remaining Lease Term WeightedAverageRemainingLeaseTerm	P3Y4M24D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.105	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	255719	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	349194	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	354565	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	237867	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	233727	usd
CY2024Q1	inuvo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	19525	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1450597	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	280701	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1169896	usd
CY2024Q1	inuvo	Finance Lease Principal And Interest Payments On Liability FinanceLeasePrincipalAndInterestPaymentsOnLiability	17350	usd
CY2024Q1	inuvo	Weighted Average Remaining Lease Terms WeightedAverageRemainingLeaseTerms	P1Y2M12D
CY2024Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0625	pure
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	33057	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	18491	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	51548	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	1244	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	50304	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1645045	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1440678	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1100000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	786549	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	62587	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	582189	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	4700	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	7	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	487158	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1645045	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	487158	usd
CY2023	inuvo	Increase Decrease In Allowance For Doubtful Accounts Receivable IncreaseDecreaseInAllowanceForDoubtfulAccountsReceivable	1157887	usd

Files In Submission

Name	View Source	Status
0001654954-24-005713-index-headers.html	Edgar Link	pending
0001654954-24-005713-index.html	Edgar Link	pending
0001654954-24-005713.txt	Edgar Link	pending
0001654954-24-005713-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
inuvo-20240331.xsd	Edgar Link	pending
inuvo_10q.htm	Edgar Link	pending
inuvo_10qimg2.jpg	Edgar Link	pending
inuvo_ex11.htm	Edgar Link	pending
inuvo_ex231.htm	Edgar Link	pending
inuvo_ex231img1.jpg	Edgar Link	pending
inuvo_ex311.htm	Edgar Link	pending
inuvo-20240331_def.xml	Edgar Link	unprocessable
inuvo-20240331_lab.xml	Edgar Link	unprocessable
inuvo-20240331_pre.xml	Edgar Link	unprocessable
inuvo_10q_htm.xml	Edgar Link	completed
inuvo_ex312.htm	Edgar Link	pending
inuvo_ex321.htm	Edgar Link	pending
inuvo_ex322.htm	Edgar Link	pending
inuvo_ex51.htm	Edgar Link	pending
inuvo_ex51img10.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
inuvo-20240331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INUV
Inuvo, Inc. Stock $inuv

2024 Q2 Form 10-Q Financial Statement

#000165495424005713 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV Inuvo, Inc. Stock $inuv

2024 Q2 Form 10-Q Financial Statement

#000165495424005713 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INUV
Inuvo, Inc. Stock $inuv